IP insight

Your Engineers Created 47 Patentable Ideas Last Year. You Filed 3. Here Is the Triage System That Decides Which Ones Actually Matter.

Hayat Amin · Updated 2026-11-22

Most companies either file too few patents or file the wrong ones. A patent triage system scores every innovation on commercial value, defensibility, and enforcement potential — so you stop wasting budget on patents that will never earn a pound.

Most companies file patents based on what their engineers think is clever. That is the wrong filter. The right filter is what an acquirer, investor, or licensee would pay for. The gap between clever and commercially valuable is where patent budgets get wasted and real IP opportunities get missed.

Hayat Amin argues that the patent filing decision is the highest-leverage IP decision a company makes — and most companies delegate it to the wrong person. According to the 2025 WIPO Global Innovation Index, patent filing costs increased 18% year over year while the percentage of patents generating licensing revenue held flat at roughly 5%. Companies are spending more to file patents that earn nothing. A triage system fixes this.

Why Do Most Companies File the Wrong Patents?

Most companies file the wrong patents because they confuse technical novelty with commercial value. An invention can be genuinely new and still worth nothing as a patent — if no competitor needs to use the technique, no licensee will pay for it, and no acquirer will price it into their offer.

The root cause is process. In most organisations, the patent filing pipeline starts with an engineer writing an invention disclosure, a patent attorney reviewing it for novelty and non-obviousness, and a decision-maker approving the filing based on legal merit. Notice what is missing: nobody asks whether this patent will generate revenue, block a competitor, or increase the company's exit multiple.

Hayat Amin's view is direct: a patent filing decision that starts with the question "is this novel?" ends with a portfolio full of patents nobody will license. The question that matters is "will this patent protect revenue, create licensing income, or increase our valuation?"

This is not theoretical. Beyond Elevation's portfolio reviews consistently find that 60% to 70% of filed patents in a typical startup portfolio have zero commercial application. The maintenance fees alone on those patents cost £15,000 to £40,000 per year — money that could fund two or three filings on innovations that actually drive value.

What Is a Patent Triage System?

A patent triage system is a structured scoring process that evaluates every patentable innovation against commercial criteria before a filing decision is made. It replaces gut feel and legal-only review with a repeatable framework that ranks innovations by their financial impact — not their technical elegance.

The system works like a medical triage. Not every patient gets the same treatment. Not every innovation deserves a patent filing. Some innovations are better protected as trade secrets. Some are better published defensively to prevent competitors from patenting them. Some should be filed immediately because the competitive window is closing. The triage system makes this decision explicit, documented, and consistent.

A functioning patent triage system requires three inputs: a complete inventory of patentable innovations (typically captured through an invention disclosure programme), a commercial scoring rubric, and a decision-maker who understands both the technology and the business model. That decision-maker is a Chief IP Officer — not a patent attorney.

How Does the Hayat Amin Patent Triage Matrix Work?

Hayat Amin's Patent Triage Matrix scores every innovation on five dimensions, each rated 1 to 5. The total score determines the filing action: file immediately, file within six months, protect as trade secret, publish defensively, or discard. The five dimensions are revenue protection, competitive blocking, licensing potential, enforcement feasibility, and filing cost efficiency.

Revenue protection (weight: 30%). Does this innovation underpin a current or planned revenue stream? A patent on a core product feature that drives customer purchasing decisions scores 5. A patent on an internal tooling improvement with no customer-facing impact scores 1.

Competitive blocking (weight: 25%). Does this innovation prevent a named competitor from entering your market or replicating your approach? Score 5 if a competitor would need to license your patent to ship their product. Score 1 if easy design-around alternatives exist.

Licensing potential (weight: 20%). Could a third party generate revenue using this patented technique? The highest scores go to innovations with broad applicability across multiple industries or use cases — the kind of patent that generates recurring licensing income.

Enforcement feasibility (weight: 15%). Can you detect infringement without access to a competitor's internal systems? Software method patents that operate invisibly inside a server score low on enforcement. Hardware patents with externally observable features score high. If you cannot prove infringement, the patent has limited deterrent value.

Filing cost efficiency (weight: 10%). What is the cost-to-file relative to the expected return? A provisional filing at £2,500 on a high-scoring innovation is excellent cost efficiency. A full international filing at £80,000 on a narrow improvement with uncertain commercial value is poor cost efficiency.

Innovations scoring 20 to 25 get filed immediately. Scores of 15 to 19 go into a six-month review queue. Scores of 10 to 14 are evaluated for trade secret protection. Below 10, the innovation is published defensively or discarded.

What Happens When You Get Patent Triage Wrong?

Getting patent triage wrong costs companies in two directions. Filing too many low-value patents drains budget. Missing high-value filing opportunities hands competitors free access to your most defensible innovations.

The budget drain is quantifiable. A single US utility patent costs £10,000 to £25,000 to file and prosecute through to grant. International extension via PCT adds £30,000 to £60,000. Annual maintenance fees run £1,500 to £4,000 per patent per jurisdiction. A portfolio of 20 low-value patents can cost £150,000 or more over their lifetime while generating zero revenue, zero competitive advantage, and zero valuation premium.

The missed opportunity cost is harder to measure but larger. Hayat Amin reminds founders of a consistent pattern: the patents that drive 80% or more of a portfolio's value are typically the ones that almost did not get filed. They looked like small improvements at disclosure stage. They turned out to cover techniques that entire product categories depend on. A triage system catches these by scoring commercial impact, not just novelty.

Companies with patents are 10.2 times more likely to secure early-stage funding. But investors do not count patents. They evaluate whether the patents create defensibility. Ten well-triaged patents that map to revenue and block competitors are worth more in a fundraise than fifty untriaged filings that cover engineering curiosities.

Who Should Run the Patent Triage Process?

The patent triage process should be led by a Chief IP Officer who reports to the CEO, not by outside patent counsel who bills by the filing. The incentive structure matters: a law firm earns more when you file more. A CIPO earns their role by ensuring every filing creates commercial value.

Beyond Elevation places fractional Chief IP Officers who run this triage as a core part of the engagement. The first 90 days of a fractional CIPO engagement typically include a full portfolio audit, an invention disclosure review, and the installation of a triage system that runs quarterly.

Hayat Amin built this process after auditing portfolios where founders had spent £200,000 or more on patents without a single filing mapped to a revenue stream. The fix is not to file fewer patents. The fix is to file the right patents — and the triage matrix is the tool that tells you which ones those are.

Book a free call with Beyond Elevation to run a patent triage on your portfolio — and find out which of your innovations deserve protection and which are draining budget. beyondelevation.com/call

FAQ

How often should a company run a patent triage review?

Quarterly is the standard cadence for companies with active R&D. Each quarter, new invention disclosures enter the pipeline and market conditions shift — a competitor's new filing may elevate the urgency of an innovation that scored low three months ago. Annual reviews are the minimum for companies with slower innovation cycles.

How much does it cost to set up a patent triage system?

A fractional Chief IP Officer can install a working triage system within the first 60 to 90 days of engagement. At typical fractional CIPO rates of £3,000 to £8,000 per month, the setup cost is a fraction of the savings from eliminating even two or three low-value patent filings per year.

Can a patent attorney run the triage instead of a CIPO?

A patent attorney provides essential technical input — novelty assessment, prior art analysis, claim drafting. But the commercial scoring that determines filing priority requires business context that most patent attorneys do not have: revenue data, competitive strategy, licensing market knowledge, and acquirer priorities. The CIPO integrates both inputs. The attorney provides one of them.

What if we have already filed patents that would score low on the triage matrix?

Run the triage retrospectively. Patents that score below 10 are candidates for abandonment — stopping maintenance fee payments frees budget for high-value new filings. Beyond Elevation's portfolio pruning process typically identifies 20% to 40% of a portfolio as candidates for abandonment, redirecting £20,000 to £80,000 per year toward patents that actually drive value.

The position behind it

The Chief IP Officer position →

Keep reading

All insights →

IP insight

Your Engineers Created 47 Patentable Inventions Last Year. You Captured Zero. Here Is the Fix.

Read the insight ↗

IP insight

Know-How vs Patent: The 20-Year Trade-Off That Decides Whether You File or Stay Silent

Read the insight ↗

AI insight

Is Your AI a Trade Secret, a Patent, or Worthless? The 4-Question Test That Tells You Which IP Vehicle Actually Protects Your Model

Read the insight ↗

IP insight

Your Biggest Competitor Filed 19 Patents Last Quarter. You Have Not Checked Once.

Read the insight ↗

Georgina KingClara Hawkins

Still reading? Talk it through instead.A free 30-minute call with Hayat Amin, set up by Clara. Straight answer, no pitch, if there is nothing worth doing, we say so.

Book a free call ↗